Evidence map›Paper›PMID 15016873›Full record

ArticleJournal of virology2004

High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylate the hepatitis C virus NS5A protein.

Carlos Coito, Deborah L Diamond, Petra Neddermann, Marcus J Korth, Michael G Katze

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cellular cofactors affecting hepatitis C virus infection and replication.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Carlos CoitoDepartment of Microbiology, Washington National Primate Research Center, University of Washington, Seattle, Washington 98195, USA.
Deborah L Diamond
Petra Neddermann
Marcus J Korth
Michael G Katze
IRBM Science Park · ITUniversity of Washington · US

Funding

PROTEOMICS COREP30DA015625 · NIDA · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 2002 to 2012
$18.9M
HEPATITIS C VIRUS:PATHOGENESIS AND CELLULAR SIGNALINGR01AI047304 · NIAID · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 2001 to 2005
$1.6M
NIAID NIH HHS R01 AI047304NIAID NIH HHS R01 AI47304NIDA NIH HHS P30 DA015625NIDA NIH HHS P30DA015625
6 · The paper itself

Abstract

The hepatitis C virus NS5A protein plays a critical role in virus replication, conferring interferon resistance to the virus through perturbation of multiple intracellular signaling pathways. Since NS5A is a phosphoprotein, it is of considerable interest to understand the role of phosphorylation in NS5A function. In this report, we investigated the phosphorylation of NS5A by taking advantage of 119 glutathione S-transferase-tagged protein kinases purified from Saccharomyces cerevisiae to perform a global screening of yeast kinases capable of phosphorylating NS5A in vitro. A database BLAST search was subsequently performed by using the sequences of the yeast kinases that phosphorylated NS5A in order to identify human kinases with the highest sequence homologies. Subsequent in vitro kinase assays and phosphopeptide mapping studies confirmed that several of the homologous human protein kinases were capable of phosphorylating NS5A. In vivo phosphopeptide mapping revealed phosphopeptides common to those generated in vitro by AKT, p70S6K, MEK1, and MKK6, suggesting that these kinases may phosphorylate NS5A in mammalian cells. Significantly, rapamycin, an inhibitor commonly used to investigate the mTOR/p70S6K pathway, reduced the in vivo phosphorylation of specific NS5A phosphopeptides, strongly suggesting that p70S6 kinase and potentially related members of this group phosphorylate NS5A inside the cell. Curiously, certain of these kinases also play a major role in mRNA translation and antiapoptotic pathways, some of which are already known to be regulated by NS5A. The findings presented here demonstrate the use of high-throughput screening of the yeast kinome to facilitate the major task of identifying human NS5A protein kinases for further characterization of phosphorylation events in vivo. Our results suggest that this novel approach may be generally applicable to the screening of other protein biochemical activities by mechanistic class.

Indexed as

Sequence HomologyAnimalsCell-Free SystemCell LineComputational BiologyHepacivirusHumansPeptide MappingPhosphopeptidesPhosphorylationProtein Kinase InhibitorsProtein KinasesProtein Serine-Threonine KinasesRibosomal Protein S6 Kinases, 70-kDaRNA-Dependent RNA PolymeraseSaccharomyces cerevisiaeMTOR protein, humanNS-5 protein, hepatitis C virusPhosphopeptidesProtein Kinase InhibitorsProtein KinasesProtein Serine-Threonine KinasesRibosomal Protein S6 Kinases, 70-kDaRNA-Dependent RNA PolymeraseSaccharomyces cerevisiae ProteinsSirolimusTOR Serine-Threonine KinasesViral Nonstructural Proteins

Identifiers

PMID15016873
PMCPMC371080
OpenAlexW2111154506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.